Improvement in Cognitive Processing Speed with Ofatumumab in Patients with Relapsing Multiple Sclerosis

被引:0
|
作者
Benedict, R. H. B. [1 ]
Penner, I. -K. [2 ]
Cutter, G. [3 ]
Kappos, L. [4 ,5 ,6 ,7 ,8 ,9 ]
Coyle, P. K. [10 ]
Piani-Meier, D. [11 ]
Azmon, A. [11 ]
Boer, I. [11 ]
Su, W. [12 ]
Cohen, J. [13 ]
机构
[1] Univ Buffalo, Dept Neurol, Buffalo, NY USA
[2] Heinrich Heine Univ, COGITO Ctr Appl Neurocognit & Neuropsychol Res, Dept Neurol, Med Fac, Dusseldorf, Germany
[3] UAB Sch Publ Hlth, Birmingham, AL USA
[4] Univ Hosp, Res Ctr Clin Neuroimmunol & Neurosci Basel, Basel, Switzerland
[5] Univ Hosp, MS Ctr, Dept Head Spine & Neuromed, Basel, Switzerland
[6] Univ Hosp, MS Ctr, Dept Clin Res, Basel, Switzerland
[7] Univ Hosp, MS Ctr, Dept Biomed, Basel, Switzerland
[8] Univ Hosp, MS Ctr, Dept Biomed Engn, Basel, Switzerland
[9] Univ Basel, Basel, Switzerland
[10] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA
[11] Novartis Pharma AG, Basel, Switzerland
[12] Novartis Pharmaceut, E Hanover, NJ USA
[13] Cleveland Clin, Neurol Inst, Dept Neurol, Mellen MS Ctr, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OPR-130
引用
收藏
页码:149 / 149
页数:1
相关论文
共 50 条
  • [1] Improvement in Cognitive Processing Speed With Ofatumumab in Patients With Relapsing Multiple Sclerosis
    Benedict, Ralph
    Penner, Iris Katharina
    Cutter, Gary
    Kappos, Ludwig
    Coyle, Patricia
    Piani-Meier, Daniela
    Azmon, Amin
    Boer, Ibolya
    Su, Wendy
    Cohen, Jeffrey
    NEUROLOGY, 2023, 100 (17)
  • [2] Ofatumumab for relapsing forms of multiple sclerosis
    Gajofatto, Alberto
    Orlandi, Riccardo
    DRUGS OF TODAY, 2022, 58 (01) : 9 - 21
  • [3] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [4] LONG-TERM EFFICACY OF OFATUMUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    Hauser, Stephen
    Fox, Edward
    Aungst, Angela
    Su, Wendy
    Zielman, Ronald
    Das Gupta, Ayan
    Stoneman, Dee
    Robertson, Derrick
    Cohen, Jeffrey
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [5] Longer-term Efficacy of Ofatumumab in Patients with Relapsing Multiple Sclerosis
    Kappos, L.
    Fox, E.
    Aungst, A.
    Su, W.
    Zielman, R.
    Gupta, A.
    Xi, J.
    Stoneman, D.
    Robertson, D.
    Cohen, J.
    Hauser, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 284 - 285
  • [6] Longer-term Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis
    Sacca, F.
    Hauser, S.
    Cross, A.
    Winthrop, K.
    Wiendl, H.
    Nicholas, J.
    Meuth, S.
    Giacomini, P.
    Zielman, R.
    Hu, X.
    Gupta, A.
    Sullivan, R.
    DeLasHeras, V.
    Su, W.
    Kappos, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 152 - 152
  • [7] LONG-TERM SAFETY OF OFATUMUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    Hauser, Stephen
    Cross, Anne
    Winthrop, Kevin
    Wiendl, Heniz
    Nicholas, Jacqueline
    Meuth, Sven
    Giacomini, Paul
    Sacca, Francesco
    Su, Wendy
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [8] Cognitive aging in patients with multiple sclerosis: an analysis of processing speed
    Boding, Angela M.
    Denney, Doughlas R.
    Lynch, Sharon G.
    MULTIPLE SCLEROSIS, 2008, 14 : S255 - S255
  • [9] Cognitive improvement on executive functions in ocrelizumab treated patients with relapsing multiple sclerosis
    Gomez Gonzalvez, Blanca
    Martin-Bernal, Jose
    Porras-Ketterer, Sebastian
    Garcia-Gimenez, Carmen
    Vidal-Mena, David
    Fajardo Sanchis, Juan Miguel
    Bermejillo Barrera, Juan Joaquin
    Carreon-Guarnizo, Ester
    Perez Vicente, Jose Antonio
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1062 - 1062
  • [10] Correction to: Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis
    Connie Kang
    Hannah A. Blair
    Drugs, 2022, 82 (1) : 63 - 63